Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 37,583 |
|
|||||
| News | - | ||||||
| Day High | 0.929799 | Low High |
|||||
| Day Low | 0.86 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| MiNK Therapeutics Inc | INKT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.018 | 2.07% | 0.889 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.86 | 0.86 | 0.929799 | 0.889 | 0.871 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 444 | 37,583 | $ 0.8971957 | $ 33,719 | - | 0.75 - 3.34 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:17:39 | 2 | $ 0.9199 | USD |
MiNK Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 30.03M | 34.52M | - | 0 | -22.46M | -0.65 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
MiNK Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INKT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.89 | 0.96 | 0.86 | 0.8804851 | 48,004 | -0.001 | -0.11% |
| 1 Month | 0.93 | 1.90 | 0.86 | 1.31 | 197,484 | -0.041 | -4.41% |
| 3 Months | 0.85 | 1.90 | 0.78 | 1.17 | 99,722 | 0.039 | 4.59% |
| 6 Months | 0.9882 | 1.90 | 0.75 | 1.11 | 71,136 | -0.0992 | -10.04% |
| 1 Year | 2.11 | 3.34 | 0.75 | 1.49 | 98,093 | -1.22 | -57.87% |
| 3 Years | 12.04 | 22.155 | 0.75 | 3.08 | 113,095 | -11.15 | -92.62% |
| 5 Years | 12.04 | 22.155 | 0.75 | 3.08 | 113,095 | -11.15 | -92.62% |
MiNK Therapeutics Description
| MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses. |
